349 related articles for article (PubMed ID: 25221855)
1. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
2. Dornase alfa for cystic fibrosis.
Yang C; Chilvers M; Montgomery M; Nolan SJ
Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
[TBL] [Abstract][Full Text] [Related]
3. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
[TBL] [Abstract][Full Text] [Related]
4. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
[TBL] [Abstract][Full Text] [Related]
5. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
6. The use of pulmonary clearance medications in the acutely ill patient.
Papacostas MF; Luckett P; Hupp S
Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
[TBL] [Abstract][Full Text] [Related]
7. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
10. The overuse or underuse of dornase alfa.
Shah PL; Hodson ME
Curr Opin Pulm Med; 1997 Nov; 3(6):410-3. PubMed ID: 9391759
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized agents for airway clearance in cystic fibrosis.
Southern KW; Clancy JP; Ranganathan S
Pediatr Pulmonol; 2019 Jun; 54(6):858-864. PubMed ID: 30884217
[TBL] [Abstract][Full Text] [Related]
12. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
Hurt K; Bilton D
Respiration; 2014; 88(6):441-8. PubMed ID: 25472021
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Boogaard R; de Jongste JC; Merkus PJ
Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
[TBL] [Abstract][Full Text] [Related]
14. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
15. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
[TBL] [Abstract][Full Text] [Related]
16. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Main E; Grillo L; Rand S
Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
[TBL] [Abstract][Full Text] [Related]
17. Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis.
Amirav I; Cohen-Cymberknoh M; Shoseyov D; Kerem E
Paediatr Respir Rev; 2009 Jun; 10(2):58-62. PubMed ID: 19410203
[TBL] [Abstract][Full Text] [Related]
18. The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis.
Reeves EP; McElvaney NG
Am J Respir Crit Care Med; 2012 Jan; 185(2):226-7. PubMed ID: 22351955
[No Abstract] [Full Text] [Related]
19. [Inhaled therapies for cystic fibrosis].
Lahzami S; Nicod LP
Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice.
Terlizzi V; Masi E; Francalanci M; Taccetti G; Innocenti D
Ital J Pediatr; 2021 Aug; 47(1):168. PubMed ID: 34362426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
